We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$50.8B
AUM Growth
-$294M
Cap. Flow
-$328M
Cap. Flow %
-0.65%
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$255M
2
TXT icon
Textron
TXT
+$206M
3
AZN icon
AstraZeneca
AZN
+$164M
4
XOM icon
ExxonMobil
XOM
+$124M
5
MRNA icon
Moderna
MRNA
+$121M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$962M
2
WORK
Slack Technologies, Inc.
WORK
+$204M
3
DVN icon
Devon Energy
DVN
+$201M
4
PRAH
PRA Health Sciences, Inc.
PRAH
+$170M
5
CARR icon
Carrier Global
CARR
+$155M

Sector Composition

Rank Sector Weight
1 Technology 22.3%
2 Healthcare 15.98%
3 Financials 14.49%
4 Consumer Discretionary 11.52%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INCY icon
551
Incyte
INCY
$24B
$15.7M 0.03%
228,547
-199,825
-47% -$15.2M
GLW icon
552
Corning
GLW
$135B
$15.7M 0.03%
429,621
-326,800
-43% -$13M
TPBAU
553
DELISTED
TPB Acquisition Corporation I Unit
TPBAU
$15.7M 0.03%
+1,575,000
New +$15.7M
RDS.A
554
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$15.6M 0.03%
350,000
-2,800,000
-89% -$113M
XPO icon
555
XPO
XPO
$23B
$15.5M 0.03%
+327,547
New +$16.4M
CARR icon
556
Carrier Global
CARR
$52.7B
$15.4M 0.03%
298,429
-2,887,933
-91% -$155M
KALV
557
DELISTED
KalVista Pharmaceuticals
KALV
$15.4M 0.03%
884,339
-661
-0.1% -$13.4K
IPG
558
DELISTED
Interpublic Group of Companies
IPG
$15.4M 0.03%
420,172
-601,100
-59% -$21.5M
KCGI.U
559
DELISTED
Kensington Capital Acquisition Corp. V Units, each consisting of one Class A ordinary share and three-fourths of one redeemable warrant
KCGI.U
$15.3M 0.03%
+1,500,000
New +$15.2M
GTM
560
ZoomInfo Technologies
GTM
$1.22B
$15.3M 0.03%
+250,000
New +$15M
NUE icon
561
Nucor
NUE
$61.9B
$15.3M 0.03%
155,035
-154,500
-50% -$16.4M
EVRG icon
562
Evergy
EVRG
$19.1B
$15.2M 0.03%
244,782
-818
-0.3% -$53.6K
PFG icon
563
Principal Financial Group
PFG
$24.7B
$15.1M 0.03%
234,300
-43,800
-16% -$2.81M
LKQ icon
564
LKQ Corp
LKQ
$6.19B
$15.1M 0.03%
299,700
-4,200
-1% -$214K
LNT icon
565
Alliant Energy
LNT
$18B
$15M 0.03%
268,008
-3,900
-1% -$230K
MAS icon
566
Masco
MAS
$14.9B
$14.9M 0.03%
+268,600
New +$15.9M
SMTC icon
567
Semtech
SMTC
$12.6B
$14.9M 0.03%
191,040
+13,000
+7% +$890K
GHLD
568
DELISTED
Guild Holdings
GHLD
$14.8M 0.03%
1,077,908
-19,377
-2% -$292K
AVIR icon
569
Atea Pharmaceuticals
AVIR
$399M
$14.8M 0.03%
422,210
-475,000
-53% -$13.2M
GSEV
570
DELISTED
Gores Holdings VII, Inc. Class A Common Stock
GSEV
$14.8M 0.03%
1,500,000
– –
SNAP icon
571
Snap
SNAP
$8.83B
$14.8M 0.03%
200,000
-300,000
-60% -$21.7M
OKLO
572
Oklo
OKLO
$7.34B
$14.7M 0.03%
+1,500,000
New +$14.8M
KYMR icon
573
Kymera Therapeutics
KYMR
$8.75B
$14.7M 0.03%
250,000
+150,000
+150% +$8.7M
LNC icon
574
Lincoln National
LNC
$8.93B
$14.7M 0.03%
213,261
-132,700
-38% -$8.67M
APGB
575
DELISTED
Apollo Strategic Growth Capital II
APGB
$14.7M 0.03%
1,500,000
– –
21 22
23
24 25

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
  • Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
  • Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
  • Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
  • Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
  • Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
  • Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.

Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.